Nitroglycerin Controlled Release Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 2.6 mg, 6.5 mg, 9 mg
Reference Brands: Various Indian Brand Available
Category:
Heart Disorder
Nitroglycerin Controlled Release Tablet is used to treat and prevent heart-related chest pain (angina). Angina occurs when the heart muscle is not getting enough blood. This medicine works by relaxing and widening blood vessels so blood can flow more easily to the heart.
Nitroglycerin Controlled Release Tablets is available in Tablets
and strengths such as 2.6 mg, 6.5 mg, 9 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nitroglycerin Controlled Release Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nitroglycerin Controlled Release Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nitroglycerin Controlled Release Tablets are a cardiovascular medication designed for the prevention of angina pectoris (chest pain) in patients with coronary artery disease. The active ingredient, nitroglycerin, is a nitrate that works by releasing nitric oxide in the body, which relaxes and dilates blood vessels. This vasodilation improves blood flow to the heart muscle and reduces the heart’s workload, helping prevent episodes of angina.
Unlike sublingual tablets, controlled-release tablets are formulated to provide a gradual and sustained release of nitroglycerin over 12–24 hours. This ensures steady blood levels of the drug, allowing prolonged protection against angina attacks and reducing the need for frequent dosing. The tablets are available in various strengths, typically 2.5 mg, 6.5 mg, 9 mg, and 12 mg.
Nitroglycerin Controlled Release Tablets are administered orally, usually once or twice daily, under the supervision of a healthcare professional. They are widely used in clinical settings for long-term management of angina and are available globally in both branded and generic formulations, manufactured under strict GMP standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing